Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
iRhythm completes VitalConnect acquisition for $237.5 million cash, issues up to 423,334 shares

iRhythm completes VitalConnect acquisition for $237.5 million cash, issues up to 423,334 shares

BitgetBitget2026/10/05 13:13

iRhythm completed its acquisition of VitalConnect, adding wearable biosensors, mobile cardiac telemetry, and multi-vitals monitoring across ambulatory and inpatient settings. Purchase consideration included USD 237.5 million cash, up to 423,334 shares at closing, and USD 10 million of working-capital funding pre-close. Deal expected to expand iRhythm’s addressable market into hospital-to-home care, leveraging its health system relationships and integrated clinical services. Transaction expected to lift revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target for 2027. Updated 2026 guidance including VitalConnect is planned for the third-quarter earnings call on Nov. 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050905PRIMZONEFULLFEED9839527) on October 05, 2026, and is solely responsible for the information contained therein.

  • iRhythm completed its acquisition of VitalConnect, adding wearable biosensors, mobile cardiac telemetry, and multi-vitals monitoring across ambulatory and inpatient settings.
  • Purchase consideration included USD 237.5 million cash, up to 423,334 shares at closing, and USD 10 million of working-capital funding pre-close.
  • Deal expected to expand iRhythm’s addressable market into hospital-to-home care, leveraging its health system relationships and integrated clinical services.
  • Transaction expected to lift revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target for 2027.
  • Updated 2026 guidance including VitalConnect is planned for the third-quarter earnings call on Nov. 5, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050905PRIMZONEFULLFEED9839527) on October 05, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!